123
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Involvement of heme oxygenase-1 in suppression of T cell activation by quercetin

, , , , , & show all
Pages 295-305 | Received 01 Apr 2019, Accepted 13 Apr 2020, Published online: 12 May 2020

References

  • Suthanthiran M, Strom TB. Immunobiology and immunopharmacology of organ allograft-rejection. J Clin Immunol. 1995;15(4):161–171.
  • Akdis M, Aab A, Altunbulakli C, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2016;138(4):984–1010.
  • O'Keefe SJ, Tamura J, Kincaid RL, et al. FK-506-sensitive and CSA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature. 1992;357(6380):692–694.
  • Calne RY, Rolles K, Thiru S, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs – 32 kidneys, 2 pancreases, and 2 livers. Lancet. 1979;314(8151):1033–1036.
  • Fung JJ, Abu-Elmagd K, Todo S, et al. Overview of FK506 in transplantation. Clin Transpl. 1990;4:115–121.
  • Ekberg H. Calcineurin inhibitor sparing in renal transplantation. Transplantation. 2008;86(6):761–767.
  • Middleton E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000;52(4):673–751.
  • Pietta PG. Flavonoids as antioxidants. J Nat Prod. 2000;63(7):1035–1042.
  • Raffa D, Maggio B, Raimondi MV, et al. Recent discoveries of anticancer flavonoids. Eur J Med Chem. 2017;142:213–228.
  • Rodriguez-Mateos A, Vauzour D, Krueger CG, et al. Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update. Arch Toxicol. 2014;88(10):1803–1853.
  • Wang WY, Sun CX, Mao LK, et al. The biological activities, chemical stability, metabolism and delivery systems of quercetin: a review. Trends Food Sci Technol. 2016;56:21–38.
  • Hushmendy S, Jayakumar L, Hahn AB, et al. Select phytochemicals suppress human T-lymphocytes and mouse splenocytes suggesting their use in autoimmunity and transplantation. Nutr Res. 2009;29(8):568–578.
  • Matsushima M, Takagi K, Ogawa M, et al. Heme oxygenase-1 mediates the anti-allergic actions of quercetin in rodent mast cells. Inflamm Res. 2009;58(10):705–715.
  • Loboda A, Damulewicz M, Pyza E, et al. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73(17):3221–3247.
  • Julius MH, Simpson E, Herzenberg LA. Rapid method for isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973;3(10):645–649.
  • Ogasawara N, Matsushima M, Kawamura N, et al. Modulation of immunological activity on macrophages induced by diazinon. Toxicology. 2017;379:22–30.
  • Wang H, Zhou CL, Lei H, et al. Inhibition of calcineurin by quercetin in vitro and in Jurkat cells. J Biochem. 2010;147(2):185–190.
  • Lei H, Luo J, Tong L, et al. Quercetin binds to calcineurin at a similar region to cyclosporin A and tacrolimus. Food Chem. 2011;127(3):1169–1174.
  • Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annual review of immunology. Vol. 27. Palo Alto: Annual Reviews; 2009. p. 591–619.
  • Yachie A, Niida Y, Wada T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999;103(1):129–135.
  • Soares MP, Marguti I, Cunha A, et al. Immunoregulatory effects of HO-1: how does it work? Curr Opin Pharmacol. 2009;9(4):482–489.
  • Pae HO, Oh GS, Choi BM, et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol. 2004;172(8):4744–4751.
  • Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol. 2012;12(3):180–190.
  • Song RP, Zhou ZH, Kim PKM, et al. Carbon monoxide promotes Fas/CD95-induced apoptosis in Jurkat cells. J Biol Chem. 2004;279(43):44327–44334.
  • McDaid J, Yamashita K, Chora A, et al. Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells. FASEB J. 2005;19(3):1–22.
  • Duckles H, Boycott HE, Al-Owais MM, et al. Heme oxygenase-1 regulates cell proliferation via carbon monoxide-mediated inhibition of T-type Ca2+ channels. Pflugers Arch Eur J Physiol. 2015;467(2):415–427.
  • Nakamura T, Matsushima M, Hayashi Y, et al. Attenuation of transforming growth factor-beta-stimulated collagen production in fibroblasts by quercetin-induced heme oxygenase-1. Am J Respir Cell Mol Biol. 2011;44(5):614–620.
  • Hayashi Y, Matsushima M, Nakamura T, et al. Quercetin protects against pulmonary oxidant stress via heme oxygenase-1 induction in lung epithelial cells. Biochem Biophys Res Commun. 2012;417(1):169–174.
  • Takashima K, Matsushima M, Hashimoto K, et al. Protective effects of intratracheally administered quercetin on lipopolysaccharide-induced acute lung injury. Respir Res. 2014;15(1):150.
  • Yasui M, Matsushima M, Omura A, et al. The suppressive effect of quercetin on toll-like receptor 7-mediated activation in alveolar macrophages. Pharmacology. 2015;96(5–6):201–209.
  • Ferrandiz ML, Devesa I. Inducers of heme oxygenase-1. Curr Pharm Des. 2008;14(5):473–486.
  • Woo J, Iyer S, Cornejo MC, et al. Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). Transpl Immunol. 1998;6(2):84–93.
  • Martins PNA, Kessler H, Jurisch A, et al. Induction of heme oxygenase-1 in the donor reduces graft immunogenicity. Transpl Proc. 2005;37(1):384–386.
  • Tullius SG, Nieminen-Kelha M, Buelow R, et al. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation. 2002;74(5):591–598.
  • Kato H, Amersi F, Buelow R, et al. Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant. 2001;1(2):121–128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.